Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19

Asnani, M; Hayer, KE; Naqvi, AS; Zheng, SS; Yang, SY; Oldridge, D; Ibrahim, F; Maragkakis, M; Gazzara, MR; Black, KL; Bagashev, A; Taylor, D; Mourelatos, Z; Grupp, SA; Barrett, D; Maris, JM; Sotillo, E; Barash, Y; Thomas-Tikhonenko, A

Thomas-Tikhonenko, A (corresponding author), Childrens Hosp Philadelphia, Div Canc Pathobiol, Philadelphia, PA 19104 USA.; Thomas-Tikhonenko, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Thomas-Tikhonenko, A (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.

LEUKEMIA, 2020; 34 (4): 1202